Searched for: All
Multiparametric MRI Can Detect Enhanced Myelination in the Ex Vivo Gli1-/- Mouse Brain
Lee, Choong H; Holloman, Mara; Salzer, James L; Zhang, Jiangyang
This study investigated the potential of combining multiple MR parameters to enhance the characterization of myelin in the mouse brain. We collected ex vivo multiparametric MR data at 7 T from control and Gli1-/- mice; the latter exhibit enhanced myelination at Postnatal Day 10 (P10) in the corpus callosum and cortex. The MR data included relaxivity, magnetization transfer, and diffusion measurements, each targeting distinct myelin properties. This analysis was followed by and compared to myelin basic protein (MBP) staining of the same samples. Although a majority of the MR parameters included in this study showed significant differences in the corpus callosum between the control and Gli1-/- mice, only T2, T1/T2, and radial diffusivity (RD) demonstrated a significant correlation with MBP values. Based on data from the corpus callosum, partial least square regression suggested that combining T2, T1/T2, and inhomogeneous magnetization transfer ratio could explain approximately 80% of the variance in the MBP values. Myelin predictions based on these three parameters yielded stronger correlations with the MBP values in the P10 mouse brain corpus callosum than any single MR parameter. In the motor cortex, combining T2, T1/T2, and radial kurtosis could explain over 90% of the variance in the MBP values at P10. This study demonstrates the utility of multiparametric MRI in improving the detection of myelin changes in the mouse brain.
PMID: 40174963
ISSN: 1099-1492
CID: 5819152
Mentorship in Pain Medicine Fellowship: Addressing the Gaps and Advocating for Change [Editorial]
Wahezi, Sayed E; Yener, Ugur; Staats, Peter S; Eshraghi, Yashar; Day, Miles; Schatman, Michael E; Pritzlaff, Scott G
PMCID:11952058
PMID: 40161202
ISSN: 1178-7090
CID: 5818672
Efficacy of Diagnostic Testing of Suspected Coronary Artery Disease: A Contemporary Review
Woods, Edward; Bennett, Josiah; Chandrasekhar, Sanjay; Newman, Noah; Rizwan, Affan; Siddiqui, Rehma; Khan, Rabisa; Khawaja, Muzamil; Krittanawong, Chayakrit
BACKGROUND:Coronary artery disease (CAD) is a highly prevalent condition which can lead to myocardial ischemia as well as acute coronary syndrome. Early diagnosis of CAD can improve patient outcomes through guiding risk factor modification and treatment modalities. SUMMARY/CONCLUSIONS:Testing for CAD comes with increased cost and risk; therefore, physicians must determine which patients require testing, and what testing modality will offer the most useful data to diagnose patients with CAD. Patients should have an initial risk stratification for pretest probability of CAD based on symptoms and available clinical data. Patients with a pretest probability less than 5% should receive no further testing, while patients with a high pretest probability should be considered for direct invasive coronary angiography. In patients with a pretest probability between 5 and 15%, coronary artery calcium score and or exercise electrocardiogram can be obtained to further risk stratify patients to low-risk versus intermediate-high-risk. Intermediate-high-risk patients should be tested with coronary computed tomography angiography (preferred) versus positron emission tomography or single photon emission computed tomography based on their individual patient characteristics and institutional availability. KEY MESSAGES/CONCLUSIONS:This comprehensive review aimed to describe the available CAD testing modalities, detail their risks and benefits, and propose when each should be considered in the evaluation of a patient with suspected CAD. BACKGROUND:Coronary artery disease (CAD) is a highly prevalent condition which can lead to myocardial ischemia as well as acute coronary syndrome. Early diagnosis of CAD can improve patient outcomes through guiding risk factor modification and treatment modalities. SUMMARY/CONCLUSIONS:Testing for CAD comes with increased cost and risk; therefore, physicians must determine which patients require testing, and what testing modality will offer the most useful data to diagnose patients with CAD. Patients should have an initial risk stratification for pretest probability of CAD based on symptoms and available clinical data. Patients with a pretest probability less than 5% should receive no further testing, while patients with a high pretest probability should be considered for direct invasive coronary angiography. In patients with a pretest probability between 5 and 15%, coronary artery calcium score and or exercise electrocardiogram can be obtained to further risk stratify patients to low-risk versus intermediate-high-risk. Intermediate-high-risk patients should be tested with coronary computed tomography angiography (preferred) versus positron emission tomography or single photon emission computed tomography based on their individual patient characteristics and institutional availability. KEY MESSAGES/CONCLUSIONS:This comprehensive review aimed to describe the available CAD testing modalities, detail their risks and benefits, and propose when each should be considered in the evaluation of a patient with suspected CAD.
PMCID:11965859
PMID: 39013364
ISSN: 1421-9751
CID: 5818522
Sonography of Arthritis: Inflammatory, Infectious, Depositional
Zech, John R; Walter, William R; Burke, Christopher J
Ultrasound (US) is a valuable tool in the evaluation of arthritis both for diagnosis and treatment response. Pertinent findings such as joint effusions, synovitis, bursitis, bone erosions, tenosynovitis, and enthesitis can all be readily evaluated sonographically. In this article, we describe specific considerations in the US evaluation of rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, crystalline arthritis (gout, calcium pyrophosphate deposition disease, and hydroxyapatite deposition disease), septic arthritis, and osteoarthritis with attention to certain differentiating features. The potential role of US in the diagnosis of specific arthritides is discussed, together with an overview of newer technologies and future directions.
PMID: 40164073
ISSN: 1098-898x
CID: 5818812
The Risks and Benefits of Corticosteroid Injection vs. Platelet-Rich Plasma Injections in Patients
Ishii,Haruki; Libby,Jina; Poindexter,Lauren K.; Wise,Amanda T.; Peyser,Ken; Theivakumar,Surein; McKay,Tracy Espiritu; Janakos,Maria; Portugal,Salvador E.
This review aims to compare current evidence for the use of corticosteroid injection (CSI) versus platelet-rich plasma (PRP) in the treatment of common pathologies of the shoulder, hip and knee.
ORIGINAL:0017646
ISSN: 2167-4833
CID: 5818502
Addressing the Challenge of Successful One-Stage Lumpectomy for DCIS
Feinberg, Joshua A; Miah, Pabel; DiMaggio, Charles; Pourkey, Nakisa; Chun Kim, Jennifer; Goodgal, Jenny; Guth, Amber; Axelrod, Deborah; Schnabel, Freya
BackgroundBreast conserving surgery represents the preferred surgical treatment option for patients with early-stage breast cancer. Reexcision rates are generally higher for patients undergoing lumpectomies for ductal carcinoma in situ (DCIS) compared to invasive breast cancer, as the microscopic extent of disease is difficult to assess during excision. This study investigated the clinicopathological characteristics of patients undergoing BCS for pure DCIS and reexcision rates over time, including the effect of the MarginProbe™ device.MethodsWe queried our prospectively maintained Institutional Breast Cancer Database for patients diagnosed with DCIS and treated with BCS as their primary procedure from 2010-2021. The primary endpoint was the rate of reexcision. Variables of interest included age at diagnosis, race/ethnicity, mode of diagnostic imaging, mammographic breast density, method of core biopsy, nuclear grade, size of DCIS, multifocality, DCIS subtype, and MarginProbe™ use.ResultsPapillary DCIS (P < 0.004) and larger size (P < 0.001) was associated with an increased reexcision rate. There were also differences in the method of core biopsy (P < 0.001), with stereotactic core biopsy predominating among patients who did not require reexcision (71.3% vs 49.5%). In an unadjusted estimate for the odds ratio for association, patients who had MarginProbe™ used were 81% less likely to require reexcision (OR = 0.19, 95% CI = 0.12, 0.31, P < 0.0001).ConclusionYounger age, papillary DCIS, larger DCIS size, and non-stereotactic core biopsy method were found to be associated with higher reexcision rates. Additionally, patients whose primary procedures included intraoperative margin assessment with the MarginProbe™ were significantly less likely to require reexcision.
PMID: 40173078
ISSN: 1555-9823
CID: 5819142
The Impact of Team Teaching in Nursing Education: An Integrative Review
Ito, Vicky; Lim, Fidelindo
AIM/OBJECTIVE:This integrative review examines the impact of team teaching in undergraduate and master's degree nursing programs. BACKGROUND:Increasing workloads for faculty are a challenge in nursing education. Team teaching allows shared responsibilities; work between two or more educators can help redistribute workloads and mitigate burnout. METHOD/METHODS:A systematic search of peer-reviewed articles in Cumulative Index to Nursing and Allied Health Literature, Education Resource Information Center, and PubMed yielded 12 relevant studies. RESULTS:Four key themes emerged: modeling behaviors, applying theoretical knowledge to practice, exposure to diverse perspectives, and faculty perspectives. Effective team teaching requires trust, communication, and collaboration among educators, requiring ongoing professional development. Team teaching can enhance diversity efforts in nursing education. CONCLUSION/CONCLUSIONS:Team teaching is a viable approach to optimizing the scholarship of teaching. Future research should explore educators' perspectives on team-teaching methods and measurable impacts on achieving learning outcomes.
PMID: 40162900
ISSN: 1536-5026
CID: 5818722
Optimizing bowel preparation quality for colonoscopy: consensus recommendations by the US Multi-Society Task Force on Colorectal Cancer
Jacobson, Brian C; Anderson, Joseph C; Burke, Carol A; Dominitz, Jason A; Gross, Seth A; May, Folasade P; Patel, Swati G; Shaukat, Aasma; Robertson, Douglas J
This document is an update to the 2014 recommendations for optimizing the adequacy of bowel cleansing for colonoscopy from the US Multi-Society Task Force on Colorectal Cancer, which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The US Multi-Society Task Force developed consensus statements and key clinical concepts addressing important aspects of bowel preparation for colonoscopy. The majority of consensus statements focus on individuals at average risk for inadequate bowel preparation. However, statements addressing individuals at risk for inadequate bowel preparation quality are also provided. The quality of a bowel preparation is defined as adequate when standard screening or surveillance intervals can be assigned based on the findings of the colonoscopy. We recommend the use of a split-dose bowel preparation regimen and suggest that a 2 L regimen may be sufficient. A same-day regimen is recommended as an acceptable alternative for individuals undergoing afternoon colonoscopy, but we suggest that a same-day regimen is an inferior alternative for individuals undergoing morning colonoscopy. We recommend limiting dietary restrictions to the day before a colonoscopy, relying on either clear liquids or low-fiber/low-residue diets for the early and midday meals. We suggest the adjunctive use of oral simethicone for bowel preparation before colonoscopy. Routine tracking of the rate of adequate bowel preparations at the level of individual endoscopists and at the level of the endoscopy unit is also recommended, with a target of >90% for both rates.
PMID: 40047767
ISSN: 1097-6779
CID: 5818572
European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies
Gribben, John G; Quintanilla-Martinez, Leticia; Crompton, Simon; Arends, Jann; Bardin, Christophe; Becker, Heiko; Castinetti, Frederic; Csaba, Dégi L; D'Anastasi, Melvin; Frese, Thomas; Geissler, Jan; Matuzeviciene, Reda; Mayerhoefer, Marius E; Medeiros, Rui; Morgan, Kate; Narbutas, Šarūnas; Nier, Samantha; Ricardi, Umberto; Arjona, Eugenia Trigoso; Ungan, Mehmet; Warwick, Lorna; Zucca, Emanuele
PMCID:11956721
PMID: 40171519
ISSN: 2572-9241
CID: 5819082
A Case Report: Cryptogenic Multifocal Ulcerative Stenosing Enteritis - A Diagnostic Challenge Mimicking Crohn's Disease
Luke, Naveena; De Leon, Inna Carmela; Azizi, Shayan; Katz, Seymour
INTRODUCTION/UNASSIGNED:Cryptogenic multifocal ulcerative stenosing enteritis (CMUSE) is a rare and underrecognized small bowel disorder that often mimics Crohn's disease, leading to delays in diagnosis and misdirected treatment. Given its relapsing nature and resistance to conventional inflammatory bowel disease (IBD) therapies, CMUSE presents significant diagnostic and therapeutic challenges. CASE PRESENTATION/UNASSIGNED:We present the case of a 41-year-old male with chronic anemia, fatigue, weight loss, and intermittent abdominal pain with melena, who remained undiagnosed for 9 years despite extensive evaluations. Imaging and endoscopy failed to identify a definitive cause, and management with TNF inhibitors and IL-12/IL-23 blockade provided only temporary relief. The patient required multiple surgical resections due to recurrent strictures. Pathological examination consistently revealed multifocal jejunal ulceration with stenosis but lacked granulomas, vasculitis, or systemic inflammatory markers, ultimately confirming CMUSE. Given its distinct pathology and treatment resistance, differentiating CMUSE from Crohn's disease is essential. The patient's ongoing management includes upadacitinib, a JAK1 inhibitor, which may help modulate immune pathways contributing to ulcer formation and stricture development. CONCLUSION/UNASSIGNED:This case underscores the need for heightened clinical recognition of CMUSE, particularly in patients with unexplained small bowel strictures and ulceration unresponsive to standard IBD therapies. Genetic testing may aid in distinguishing CMUSE from Crohn's disease, preventing unnecessary immunosuppressive treatments. Further research is necessary to establish effective, targeted therapies and improve outcomes for patients with this rare condition.
PMCID:11961150
PMID: 40170795
ISSN: 1662-0631
CID: 5819042